Drug repositioning by multi-aspect heterogeneous graph contrastive learning and positive-fusion negative sampling strategy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Drug repositioning by multi-aspect heterogeneous graph contrastive learning and positive-fusion negative sampling strategy

Published:2024-12 Issue: Volume:112 Page:102563
ISSN:1566-2535
Container-title:Information Fusion
language:en
Short-container-title:Information Fusion

Author:

Liu Junkai,Hu Fuyuan,Zou Quan,Tiwari Prayag^ORCID,Wu Hongjie,Ding Yijie

Publisher

Elsevier BV

Reference58 articles.

1. Alterations in processes and priorities needed for new drug development;Ann. Intern. Med.,2006

2. Key factors in the rising cost of new drug discovery and development;Dickson;Nat. Rev. Drug Discov.,2004

3. Remdesivir: A review of its discovery and development leading to emergency use authorization for treatment of COVID-19;Eastman;ACS Central Sci.,2020

4. Fusing functional connectivity with network nodal information for sparse network pattern learning of functional brain networks;Zhu;Inf. Fusion,2021

5. Deep and statistical learning in biomedical imaging: State of the art in 3D MRI brain tumor segmentation;Fernando;Inf. Fusion,2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP